Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01178398 · ClinicalTrials.gov registry record

Understanding Fish Consumption Habits During Pregnancy

A clinical trial of Nutrition, sponsored by Harvard Pilgrim Health Care.

Completed
Registry status
22
Enrollment target
1
Study location

NCT01178398: Completed study of Nutrition, sponsored by Harvard Pilgrim Health Care.

NCT01178398 is a study of Nutrition that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 22 participants, below the 3,208-participant average among 22 other Nutrition trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01178398, a study of Nutrition, has completed, sponsored by Harvard Pilgrim Health Care.

COMPLETED
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

Many pregnant women in the US do not consume enough docosahexaenoic acid (DHA), an essential nutrient found in fish. Apparently conflicting findings that fish consumption is beneficial for the developing fetus, yet potentially toxic because of mercury contamination, have created uncertainty about the appropriate fish consumption advice to provide pregnant women. The investigators objective was to determine knowledge, behaviors, and received advice regarding fish consumption among pregnant women who are infrequent consumers of fish.

Conditions Studied

Study Locations (1)

Massachusetts

  • Harvard Pilgrim Health Care Institute - Boston

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2009-10
Est. Completion 2010-03
Harvard Pilgrim Health Care

28 total trials

What the finished NCT01178398 record still lists

NCT01178398 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 3,208-participant average among 22 other Nutrition trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Nutrition appearing as the primary indexed condition, and to 0 interventions.

NCT01178398 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01178398 about?

NCT01178398 is a clinical study titled "Understanding Fish Consumption Habits During Pregnancy". Many pregnant women in the US do not consume enough docosahexaenoic acid (DHA), an essential nutrient found in fish. Apparently conflicting findings that fish consumption is beneficial for the developing fetus, yet potentially toxic because of mercury contamination, have created uncertainty about th...

What is the current status of trial NCT01178398?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2009-10. Estimated completion is 2010-03.

What conditions does trial NCT01178398 study?

This clinical trial studies the following conditions: Nutrition.

Who is sponsoring clinical trial NCT01178398?

This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01178398 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nutrition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01178398's enrollment target sits among peer trials

22 21st of 22 higher than 2 of 22 other Nutrition trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Nutrition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01178398, the US trial registry maintained by the National Library of Medicine. NCT01178398 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.